Introduction Several studies have reported increasing prevalence of prescription opioid use
among pregnant women. However, little is known regarding the effects of maternal opioid …

In this month's issue of Pediatrics, Bandoli et al 1 report the results of their study,“Prenatal
Antidepressant Use and Risk of Adverse Neonatal Outcomes,” in which they examine …

Background: Infant leukaemia is likely initiated in utero. Methods: We examined whether
analgesic use during pregnancy was associated with risk by completing telephone …

Assessing the impact of in utero exposure to various teratogenic substances has been a
central focus in the fetal and early child development literature. Much of this work has …

Objectives To identify any associations between in utero exposure to five over-the-counter
(non-prescription) analgesics (paracetamol, ibuprofen, aspirin, diclofenac, naproxen) and …

Background: Recent data suggest an increased risk of congenital anomalies with prenatal
exposure to opioid analgesics. We sought to further quantify the risk of anomalies after …

In economically developed countries up to 90% of women are prescribed medications,
including vitamins and supplements, during pregnancy. Whilst a number of adverse health …

Background Over‐the‐counter analgesics during pregnancy or infancy may be related to
neurobehavioural problems in children, but little is known about effects of different analgesic …

Background It has been debated whether mild analgesics, mainly paracetamol, adversely
affect aspects of neurodevelopment. We examined whether mother's use of paracetamol …

Introduction The opioid crisis has brought an increasing focus on the long-term outcomes of
children following prenatal opioid exposure. Evidence to date has been conflicting, which …